| Product Code: ETC9938144 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Autoimmune Diagnostics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Autoimmune Diagnostics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Autoimmune Diagnostics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume Share, By Diagnostic Tests, 2021 & 2031F |
3.6 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Autoimmune Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in the UK |
4.2.2 Technological advancements in autoimmune diagnostics |
4.2.3 Growing awareness and focus on early disease detection |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for diagnostics |
4.3.2 High costs associated with autoimmune diagnostics |
4.3.3 Limited reimbursement policies for autoimmune diagnostic tests |
5 United Kingdom (UK) Autoimmune Diagnostics Market Trends |
6 United Kingdom (UK) Autoimmune Diagnostics Market, By Types |
6.1 United Kingdom (UK) Autoimmune Diagnostics Market, By Diagnostic Tests |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Diagnostic Tests, 2021- 2031F |
6.1.3 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Autoantibody Tests?, 2021- 2031F |
6.1.4 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Complete Blood Count (CBC)?, 2021- 2031F |
6.1.5 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Antinuclear Antibody Tests?, 2021- 2031F |
6.1.6 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By C-reactive Protein (CRP), 2021- 2031F |
6.1.7 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Rheumatoid Factor Test, 2021- 2031F |
6.1.8 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Others?, 2021- 2031F |
6.2 United Kingdom (UK) Autoimmune Diagnostics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.3 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Assay Kits, 2021- 2031F |
6.2.4 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Autoimmune Diagnostics Market, By Disease Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Systemic Autoimmune Disease, 2021- 2031F |
6.3.3 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Localized Autoimmune Disease, 2021- 2031F |
6.4 United Kingdom (UK) Autoimmune Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.4.3 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.4 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.4.5 United Kingdom (UK) Autoimmune Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Autoimmune Diagnostics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Autoimmune Diagnostics Market Export to Major Countries |
7.2 United Kingdom (UK) Autoimmune Diagnostics Market Imports from Major Countries |
8 United Kingdom (UK) Autoimmune Diagnostics Market Key Performance Indicators |
8.1 Average time taken for autoimmune diagnosis |
8.2 Adoption rate of new autoimmune diagnostic technologies |
8.3 Rate of increase in autoimmune disease incidence in the UK |
9 United Kingdom (UK) Autoimmune Diagnostics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Autoimmune Diagnostics Market Opportunity Assessment, By Diagnostic Tests, 2021 & 2031F |
9.2 United Kingdom (UK) Autoimmune Diagnostics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 United Kingdom (UK) Autoimmune Diagnostics Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.4 United Kingdom (UK) Autoimmune Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Autoimmune Diagnostics Market - Competitive Landscape |
10.1 United Kingdom (UK) Autoimmune Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Autoimmune Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here